{
    "SPADE_N_14115": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14115",
            "Peptide Name": "AS-12W (synthetic AMPs, AS-12 analog, Lys-rich; XXA, UCLL1c)",
            "Source": "sequence truncation, amino acid substitution, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "IKKWFKKIFKRL",
            "Sequence Length": 12,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Anti-MRSA",
                "Anti-inflammatory"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1635.09,
            "PI": 11.39,
            "Hydrophobicity": -0.54,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Zhang M, Wang J, Li C, Wu S, Liu W, Zhou C, Ma L.2024",
                    "Reference": "Probiotics Antimicrob Proteins. 2024 Apr 8. doi: 10.1007/s12602-024-10250-2.PubMed",
                    "Title": "Cathelicidin AS-12W Derived from the Alligator sinensis and Its Antimicrobial Activity Against Drug-Resistant Gram-Negative Bacteria In Vitro and In Vivo."
                }
            ],
            "Frequent Amino Acids": "KFI",
            "Absent Amino Acids": "ACDEGHMNOPQSTUVY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 6,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (91.67%) toAS-12obtained by sequence substitution of AS-12. K: 42%; I=F: 17%.Activity: active against E. coli ATCC 25922 or 4 clinical strains (MIC 8-16 ug/ml), P. aeruginosa ATCC 27853 or 4 clinical strrains (MIC 4-8 ug/ml),  K. pneumoniae ATCC 13883 (MIC 8-64 ug/ml), A. baumannii (MIC 16 ug/ml), Gram+ S. aureus ATCC 29213 (MIC 4 ug/ml), MRSA (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), and C.albicans (MIC 16 ug/ml) or ATCC 10231 >128 ug/ml.It also showed anti-inflammatory effect (IL-6 and TNF-alpha decreased in  RAW264.7 cells) induced by LPS.MOA:bacteria:E. coli: acted on membranes. ROS detected.Animal model:mouse: P. aeruginosa sepsis: dose-dependent efficacy (22.2% to 77.8% survival) was observed (IP treatment 2.5, 5, and 10 mg/kg).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14111",
                    "Similarity": 1.0,
                    "Sequence": "GLFKKLWRKIKKWF"
                },
                {
                    "SPADE_ID": "SPADE_N_14113",
                    "Similarity": 1.0,
                    "Sequence": "LWRKIKKWFKKIFKRL"
                },
                {
                    "SPADE_ID": "SPADE_UN_05267",
                    "Similarity": 1.0,
                    "Sequence": "RIRRFIKKW"
                }
            ]
        }
    }
}